Bio-Rad to launch blood-based immunoassay kit to detect COVID-19 antibodies
The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2
The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2
Join this upcoming webinar for a review of an antibody discovery campaign targeting a cell surface receptor implicated in cancer
Emergency use authorization granted for new biomaterial collection approach
The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers
SelectScience hears from Prof. Harald Kolmar, TU Darmstadt, on an exciting new approach in cancer therapy
To be in with a chance of winning a $500 Amazon voucher, simply cast your vote for the product that has made the most difference to your research
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals
The test results are designed to enable differential diagnosis in under 2.5 hours
Recent funding from the BARDA award helped the company accelerate development and validation
In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development
New IgM and IgG antibody assays will help indicate whether a person has developed immunity against COVID-19
The scientific community is working at full speed to fight the severe acute respiratory syndrome
The rapid delivery program is designed to provide critical laboratory equipment in this time of need
Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines
The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients
Discover how using Protein A and His1K biosensors can reduce the time of screening for bispecific antibodies
OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak
The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic
These are some of the first antibody detection tests to be CE marked in Europe and available for COVID-19 testing
This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus
The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19
Coronavirus is said to be detected using Iceni Diagnostics’ rapid, point-of-care screening technology, which distinguishes it from influenza
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development